Abstract:Neuroinflammation is considered a balanced inflammatory response important in the intrinsic repair process after injury or infection. Under chronic states of disease, injury, or infection, persistent neuroinflammation results in a heightened presence of cytokines, chemokines, and reactive oxygen species that result in tissue damage. In the CNS, the surrounding microglia normally contain macrophages and other innate immune cells that perform active immune surveillance. The resulting cytokines produced by these macrophages affect the growth, development, and responsiveness of the microglia present in both white and gray matter regions of the CNS. Controlling the levels of these cytokines ultimately improves neurocognitive function and results in the repair of lesions associated with neurologic disease. MicroRNAs (miRNAs) are master regulators of the genome and subsequently control the activity of inflammatory responses crucial in sustaining a robust and acute immunological response towards an acute infection while dampening pathways that result in heightened levels of cytokines and chemokines associated with chronic neuroinflammation. Numerous reports have directly implicated miRNAs in controlling the abundance and activity of interleukins, TGF-B, NF-kB, and toll-like receptor-signaling intrinsically linked with the development of neurological disorders such as Parkinson’s, ALS, epilepsy, Alzheimer’s, and neuromuscular degeneration. This review is focused on discussing the role miRNAs play in regulating or initiating these chronic neurological states, many of which maintain the level and/or activity of neuron-specific secondary messengers. Dysregulated miRNAs present in the microglia, astrocytes, oligodendrocytes, and epididymal cells, contribute to an overall glial-specific inflammatory niche that impacts the activity of neuronal conductivity, signaling action potentials, neurotransmitter robustness, neuron-neuron specific communication, and neuron-muscular connections. Understanding which miRNAs regulate microglial activation is a crucial step forward in developing non-coding RNA-based therapeutics to treat and potentially correct the behavioral and cognitive deficits typically found in patients suffering from chronic neuroinflammation.

Nucleic acid sensing in the central nervous system: Implications for neural circuit development, function, and degeneration

Innate Immune Sensing of Viruses and Its Consequences for the Central Nervous System

Intracellular Nucleic Acid Sensors and Autoimmunity.

Sensing Self and Non-Self DNA by Innate Immune Receptors and Their Signaling Pathways

Innate immune responses to RNA: sensing and signaling

132 : Sensing of DNA by innate immune receptors

DNA Sensing by Innate Immune Receptors (INM6P.408)

Cytosolic DNA sensors in neurodegenerative diseases: from physiological defenders to pathological culprits

Role of DNA/RNA sensors and contribution to autoimmunity

Nucleic Acid Immunity

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

CNS and CNS Diseases in Relation to Their Immune System

DNA-sensing pathways in health, autoinflammatory and autoimmune diseases

Understanding nucleic acid sensing and its therapeutic applications

cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

Non-coding RNAs and neuroinflammation: implications for neurological disorders

Long 3′UTRs predispose neurons to inflammation by promoting immunostimulatory double-stranded RNA formation

The role of STING signaling in central nervous system infection and neuroinflammatory disease

cGAS-STING-mediated IFNI Response in Host Defense and Neuroinflammatory Diseases

Intracellular DNA sensing by neutrophils and amplification of the innate immune response